1. Home
  2. News
  3. NATCO Pharma Limited
  4. Press Release Mar 15 2021
More NATCO Pharma Limited news
NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Mar 15 2021

Mar 15, 2021 at 1:09 PM EDT · Issued by NATCO Pharma Limited

Filed with NSE · Mar 15, 2021 at 1:09 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/press-release-mar-15-2021-6

Watch NATCO Pharma's latest callNATCO Pharma (NSE:NATCOPHARM) Q2 2027 Earnings Call · Replay · Nov 13↗

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

  • Press Release Mar 08 2021Mar 8, 2021
  • NATCO Pharma launches Brivaracetam tablets, in India, for treatment of epilepsyMar 1, 2021
  • Press Release Feb 26 2021Feb 26, 2021
  • NATCO Pharma receives approval for Chlorantraniliprole 1st key product of Crop Health Sciences DivisionFeb 8, 2021
  • Press Release Feb 05 2021Feb 5, 2021

Later from NATCO Pharma

  • NATCO Pharma forays into Pheromone based technology for Integrated Pest ManagementMar 16, 2021
  • Press Release Apr 10 2021Apr 10, 2021
  • NATCO Pharma receives tentative approval for Ibrutinib tablets (generic for IMBRUVICA) ANDA in the US marketApr 13, 2021
  • Press Release Apr 26 2021Apr 26, 2021
  • Press Release May 03 2021May 3, 2021
All NATCO Pharma news releases↗

Follow NATCO Pharma into a list and get an email when it puts out news.

Follow NATCO Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer